Catalyst Wire Dossier Catalyst Wire Dossier

HERCEPTIN

trastuzumab · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

305 regulatory and trial events tracked for HERCEPTIN, covering 2006-11-16 to 2026-07-07. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects [Phase 1]

See pricing